Results 111 to 120 of about 549,379 (280)

Concurrent Chemoradiotherapy Followed by Adjuvant Chemotherapy Compared with Concurrent Chemoradiotherapy Alone for the Treatment of Locally Advanced Nasopharyngeal Carcinoma: A Retrospective Controlled Study

Current Oncology, 2014
Objective: We evaluated the survival benefit of providing concurrent chemoradiotherapy (ccrt) plus adjuvant chemotherapy compared with ccrt alone to patients with locally advanced nasopharyngeal carcinoma. Methods: This retrospective study included 130 patients with nasopharyngeal carcinoma treated with ccrt plus adjuvant chemotherapy from June 2005 to
Liang, Z., Zhu, X., Li, L., Qu, S., Liang, X., Liang, Z., Su, F., Li, Y., Zhao, W.   +8 more
openaire   +3 more sources

Multi-center Clinical Study of Nimotuzumab Combined with PF Regimen in Induction Treatment of Locally Advanced Nasopharyngeal Carcinoma

Zhongliu Fangzhi Yanjiu, 2019
Objective To investigate the safety and efficacy of the induction therapy of nimotuzumab combined with PF regimen (cisplatin+5-fluorouracil) in the follow-up treatment of locally advanced nasopharyngeal carcinoma patients received concurrent ...
LU Ying, CHEN Dagui, LIANG Jinhui, GAO Jianquan, LUO Zhanxiong, WANG Rensheng, LIU Wenqi, HUANG Changjie, NING Xuejian, LIU Meilian, HUANG Haixin   +10 more
doaj   +1 more source

Case Series: Natural History and Treatment of Thoracic Aortic Sarcoma

Journal of Surgical Oncology, EarlyView.
ABSTRACT Aortic sarcoma is a rare and aggressive malignancy with a poor prognosis despite surgical resection and vascular reconstruction. We present a case series of patients with thoracic aortic sarcoma, highlighting three distinct clinical scenarios: primary resection, resection following prior thoracic aortic endograft, and nonoperative management ...
Calvin L. Chao, Nicola M. Habash, Mark K. Eskandari   +2 more
wiley   +1 more source

Nimotuzumab Combined with Induction Chemotherapy and Concurrent Chemoradiotherapy in Unresectable Locally Advanced Hypopharyngeal Carcinoma: A Single Institution Experience in China

Cancer Management and Research, 2020
Xin Tian, Ying Xuan, Rong Wu, Song Gao Department of Clinical Oncology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, People’s Republic of ChinaCorrespondence: Song GaoDepartment of Clinical Oncology, Shengjing Hospital
Tian X, Xuan Y, Wu R, Gao S
doaj  

Oral glutamine supplements reduce concurrent chemoradiotherapy-induced esophagitis in patients with advanced non-small cell lung cancer

Medicine, 2019
Background: Complications related to concurrent chemoradiotherapy (CCRT) such as acute radiation-induced esophagitis (ARIE) may cause significant morbidity and unplanned treatment delays in patients with advanced non-small cell lung cancer (NSCLC).
Shih-Chieh Chang, Y. Lai, Jui-Chi Hung, Cheng-Yu Chang   +3 more
semanticscholar   +1 more source

Smoking and Elevated Preneoadjuvant Chemoradiotherapy Serum Carcinoembryonic Antigen Levels Are Associated With High Tumor Regression Grade and Poor Survival in Patients With Locally Advanced Rectal Cancer

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Neoadjuvant chemoradiotherapy (NACRT) is the standard treatment for patients with locally advanced rectal cancer (LARC). Tumor regression grade (TRG) is an essential prognostic factor in determining treatment efficacy. However, the potential factors influencing TRG in patients with rectal cancer who have received NACRT have not been ...
Jen‐Pin Chuang, Hsiang‐Lin Tsai, Po‐Jung Chen, Ching‐Wen Huang, Wei‐Chih Su, Tsung‐Kun Chang, Yen‐Cheng Chen, Ching‐Chun Li, Yung‐Sung Yeh, Jaw‐Yuan Wang   +9 more
wiley   +1 more source

Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy

BMC Cancer, 2019
Diabetes is related with increased cancer mortality across multiple cancer types. Its role in lung cancer mortality is still unclear. We aim to determine the prognostic value of fasting plasma glucose (FPG) and diabetes mellitus in patients with locally ...
Milana Bergamino, A. Rullán, M. Saigí, I. Peiró, E. Montanya, R. Palmero, J. Ruffinelli, A. Navarro, M. Arnaiz, I. Brao, S. Aso, S. Padrones, F. Cardenal, E. Nadal   +13 more
semanticscholar   +1 more source

Chemotherapy May Influence Esophageal Lugol Chromoendoscopy Severity: A Retrospective Cohort Study and Literature Review

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Lugol chromoendoscopy is widely used for screening esophageal squamous cell neoplasms (ESCNs) and evaluating dissection margins during endoscopic submucosal dissection (ESD). However, morphological variations may arise following treatment for synchronous cancers.
Wen‐Hung Hsu, Chien‐Chieh Lin, Hsiang‐Yao Shih, Leong‐Perng Chan, Hui‐Ching Wang, Yi‐Hsun Chen, Yu‐Chung Hsu, Hui‐Min Hsieh, I‐Chen Wu   +8 more
wiley   +1 more source

Comparison of weekly and triweekly cisplatin regimens during concurrent chemoradiotherapy for nasopharyngeal carcinoma

BMC Cancer, 2019
We compared the survival outcomes and acute toxicities of weekly and triweekly cisplatin regimens during concurrent chemoradiotherapy (CCRT) in nasopharyngeal carcinoma (NPC) patients. Patients were treated with CCRT alone.
Kai-lei Wang, Jun Dong, Shasha He, Xia Wang, Chang Jiang, Pi-li Hu, Jian-Gui Guo, Xiuyu Cai, Xicheng Wang   +8 more
semanticscholar   +1 more source

The Evolution of Multidisciplinary Head and Neck Cancer Treatment

The Laryngoscope, EarlyView.
ABSTRACT Objective The management of head and neck squamous cell carcinoma (HNSCC) has substantially changed over the past two centuries. This review explores the historical progression of HNSCC management focusing on the multidisciplinary treatment paradigm.
Kevin J. Contrera, Pooja D. Reddy, Vanessa Helou, Jeffrey N. Myers, Heath D. Skinner, Renata Ferrarotto, Eugene N. Myers   +6 more
wiley   +1 more source